Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global HDAC (histone deacetylase) Inhibitors Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The HDAC (histone deacetylase)…
One of three bispecific immuno-oncology therapeutics being developed under the two companies’ collaboration agreements Zymeworks to receive US$3.5 million commercial…
— Regulatory submission triggers $10 million milestone payment to Exelixis under collaboration and license agreement with Takeda — — Submission…
First-In-Human Clinical Study Will be Initiated Later in Second Quarter 2019 DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical…
MILPITAS, Calif.–(BUSINESS WIRE)–Applied StemCell, Inc. (ASC), a leading gene-editing company, announced that its therapeutic division (ASC Therapeutics) has cured Hemophilia…
LONDON–(BUSINESS WIRE)–After many successful events across the United States, Canada, Brazil, Australia, New Zealand, Malaysia, and the Philippines, Medisca UK…
DUBLIN–(BUSINESS WIRE)–The “Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) –…
Orphan drug sales reach $242bn by 2024, according to EvaluatePharma® Orphan Drug Report 2019 LONDON & BOSTON & TOKYO–(BUSINESS WIRE)–lt;a…
PLENITY manufacturing facility will be the first factory to commercially produce medical super-absorbent hydrogels synthesized from naturally derived building blocks…
PLENITY manufacturing facility will be the first factory to commercially produce medical super-absorbent hydrogels synthesized from naturally derived building blocks…